Fundraising FoxNLC
Venture studioAmsterdam · Pre-Seed–Seed · 43 people tracked
Find your way into NLC
3,986 people in our graph share verified history with the NLC team — schools, employers, funds. One of them is your warm intro.
Investment thesis
NLC Health Ventures operates as a healthtech venture builder and early-stage investor, aiming to bridge the gap between scientific discoveries and market-ready healthcare solutions. It finds, builds and scales health innovations across cardiovascular and image-guided therapy, orthopedics and spine, therapeutics (from small molecules to gene therapies spanning oncology and rare diseases), and new markets such as neonatal and respiratory technologies plus hospital enterprise software. The firm assesses over 1,500 technologies annually, has built 110+ ventures, and runs captive funds including the NLC Health Impact Fund. It combines venture creation with impact-focused investing, supported by 40+ healthcare experts and a community of founders, aiming to derisk early-stage healthcare innovation.
Source: firm website, verified Sep 27, 2026.
Team · 43 people
from the firm's website & curated
Founder mafia
3 people who came through NLC went on to found or lead other companies.
What they invest in
from 51 of 73 portfolio companiesMedical Devices ×47Healthtech ×38Biotech ×23Digital Health ×19AI & Machine Learning ×15Deep Tech ×13Hardware ×13Enterprise Software ×2
HQs:Netherlands×15United Kingdom×6United States×4France×2Austria×1Germany×1
Who they back
founder profiles across 24 portfolio companiesFounding team size:solo founder×152 founders×83 founders×1
Where their founders studiedfrom 14 founders with education data
University of Twente ×2Utrecht University ×2
What their founders studiedfrom 12 founders with field-of-study data
Engineering ×5Medicine ×3Business & Management ×2Computer Science ×2
Where their founders worked beforefrom 17 founders with career history
AMC - Academisch Medisch Centrum ×2
Investments · 73 tracked
founders shown can be your intro path
Neurolieve is a life-science company developing therapeutics for neuropathic and chronic pain, with expertise in neuroscience, clinical pain medicine and drug development.
BiotechDeep TechHealthtechMedical Devices
Co-investorsInnovate UK
Nilocas is developing a medical device with focus on human viability trials.
Deep TechDigital HealthHardwareHealthtechMedical Devices
Aerion Bioscience develops a 6-protein biomarker panel for early detection and staging of lung cancer.
BiotechDigital HealthMedical Devices
Dr. Axel Schumacher(CEO)in
A digital health company building innovative medical device solutions with a focus on advanced clinical applications.
Deep TechDigital HealthHardwareHealthtechMedical Devices
Mike Connell(Founder & CEO)inPieter Wijffels(NLC Partner and Co-founder)in
AIDO develops a robotic add-on system, combining hardware and software, that attaches to existing endoscopes to assist endoscopists with complex, non-invasive procedures such as treating colorectal cancer and performing pancreatic biopsies.
HealthtechMedical DevicesRobotics
Charlotte Cave(CEO)in
Allergios develops an in-vitro allergy diagnostic that visualizes allergic responses by analyzing how a patient's blood serum induces basophil degranulation, using a disposable microfluidic chip, an optical reader (GranulEye), and AI-based analysis software.
AI & Machine LearningDigital HealthMedical Devices
Altach Biomedical develops cartilage repair solutions for the orthopedic medical device industry.
BiotechHealthtechMedical DevicesDublin, IE
Tomir Kosowski(CEO)in
Amotio develops a guided bone cement removal system with patient-specific surgical planning and precision instrumentation for orthopaedic revision surgery, targeting arthroplasty and revision surgeons who work with cemented joint implants.
HardwareHealthtechMedical Devices
Iestyn Foster(Founder & CEO)in
Co-investorsDevelopment Bank of Wales
PCaVision is a diagnostic tool that combines multiparametric ultrasound imaging with AI algorithms to detect suspicious areas for prostate cancer, offering urologists a diagnostic pathway that does not require MRI.
AI & Machine LearningDigital HealthMedical Devices
Ansana develops sterilization process management and control solutions for healthcare and pharmaceutical organizations, focusing on patient safety and operational efficiency.
Enterprise SoftwareHealthtechIoTMedical Devices
Dominique Surinx(CEO & Co-Founder)in
Asclepius MedTech supports health technology companies with market access strategy and value proposition development for entering the NHS, drawing on NHS finance and decision-making expertise.
Digital HealthHealthtechMedical DevicesLeeds, GB
Michael Morgan Curran(Chief Executive Officer)
Co-investorsAcronym Venture CapitalComcast VenturesFlorida FundersSands Capital Ventures
Audaxis Medical develops biocompatible pelvic health implants using next-generation biomaterials designed to integrate with the body and replace legacy materials.
BiotechFemTechHealthtechMedical Devices
BoardChristopher Chapple(Co-Inventor, Senior Medical Advisor)Sheila MacNeil(Co-Inventor, Senior Medical Advisor)
Axial Orthopaedics is a medtech company in orthopedic healthcare, with leadership experienced in strategic exits.
BiotechDeep TechHealthtechMedical Devices
Craig Corrance(CEO)
Concord develops equipment and protocols for physiological-based cord clamping, enabling neonatal caregivers to provide care with the umbilical cord intact until a newborn is fully stable and breathing independently.
HardwareHealthtechLongevityMedical DevicesLeiden, NL
Arjan te Pas(Professor)Stuart Hooper(Professor)
Co-investorsUNIIQ
Crainio develops a non-invasive brain monitoring device that uses an optical sensor placed on the forehead to detect rising intracranial pressure and intracranial hypertension.
HardwareHealthtechMedical Devices
Co-investorsOxford Investment Opportunity Network (OION)
Exolvo Biosciences develops drug delivery technology.
BiotechDeep TechMedical Devices
Brian Longstreet(Co-founder & CEO)
Scanner providing immediate imaging of biopsy and surgical specimens to distinguish healthy tissue from tumors in real time.
Foveo Fertility develops solutions for fertility treatment.
Digital HealthFemTechHealthtechMedical Devices
Eva van Rooijen(CEO & Co-Founder)in
Garland Surgical develops the TriActiv Hip (formerly MaltaHip), a total hip replacement implant using a patented tri-axial design intended to improve mobility, stability, and durability while reducing revision surgeries.
HardwareHealthtechMedical DevicesWorcester, GB
Simon Mifsud(Founder & Group Chief Executive Officer)inJohn Shapland(Chief Technology Officer)in
Haermonics is a clinical-stage medtech company that developed the Haermonics Pure System, a continuous postoperative pericardial flush therapy designed to keep chest tubes clear and prevent bleeding-related complications after open-heart cardiac surgery.
HardwareHealthtechMedical DevicesEindhoven, NL
David R. Koolbergen(Inventor of the therapy; Congenital Cardiothoracic Surgeon)in
Co-investorsBOM
HapticHeart Solutions builds a device-agnostic system that converts biophysical and physiological signals from cardiac catheterization, electrophysiology, and robotic interventions into haptic feedback delivered to operators through a wearable interface and handle.
BiotechHardwareHealthtechMedical Devices
Hemeo develops AI-based clinical decision support software that consolidates data from multiple sources to predict coagulation risks and personalize the prevention and treatment of bleeding and thrombosis.
AI & Machine LearningDigital HealthHealthtechAmsterdam, NL
Rene van den Ham(Founder)in
Co-investorsMomentum
Implant Preservation Devices develops orthopedic implant devices for medical and surgical applications.
BiotechHealthtechMedical DevicesAmsterdam, NL
Richard van de Wateringen(CEO)
Kaminari Medical develops intravascular imaging technology for cardiovascular interventions, using photoacoustic and optical innovations.
BiotechDeep TechDigital HealthHealthtechMedical DevicesRotterdam, NL
Prof. Dr. Gijs van Soest(Inventor)Prof. Dr. Ton van der Steen(Inventor)Verya Daeichin(CTO/Inventor)in
Co-investorsGraduate Entrepreneur
Lamina Therapeutics develops Lamina.One, a combined advanced therapy medicinal product for bone and cartilage regeneration that pairs a biodegradable polymeric membrane with hydroxyapatite and an autologous mesenchymal stem cell hydrogel to treat knee osteoarthritis and orthopaedic, maxillofacial, and periodontal conditions.
BiotechHealthtechMedical DevicesStrasbourg, FR
Nadia Benkirane-Jessel(Founder)Stephan Lemmens(CEO)in
LarynxLock is a single-use medical device that prevents airway leakage in supraglottal airway devices, applied externally to patient skin for use in operating rooms, pre-hospital settings, and procedural sedation.
CleantechHardwareHealthtechMedical DevicesMaastricht, NL
Loresa develops minimally invasive surgical devices for resource-limited settings, with a focus on eliminating the need for insufflation in abdominal surgery.
Deep TechHardwareHealthtechImpact & Social GoodMedical Devices
Dr. Deborah MaufiWillem Fontijn
BoardEllis Aunein
LUMABS BV develops RAPPID, a rapid, one-step immunoassay technology that enables sensitive antibody detection from minimal blood samples for diagnostics and therapeutic monitoring.
AI & Machine LearningBiotechMedical Devices
MindAffect develops brain-computer interface technology that measures automatic neural responses to auditory and visual stimuli using EEG, enabling objective hearing and vision assessment for patients who cannot respond behaviorally (young children, individuals with disabilities, older adults).
AI & Machine LearningDeep TechHealthtechMedical Devices
MLA Diagnostics develops a melanoma diagnostic test based on DNA methylation biomarkers to improve patient risk stratification and treatment decisions.
BiotechDigital HealthMedical DevicesMaastricht, NL
Manon van Engeland(Inventor and Co-founder)Egbert Smit(CEO)
NC Biomatrix develops biologic therapies targeting musculoskeletal degeneration, with a lead product (VitaDisc) addressing intervertebral disc degeneration and chronic lower back pain, and ongoing research into osteoarthritis treatments for synovial joints.
BiotechHealthtechMedical Devices
Nicolab builds StrokeViewer, an AI-powered, cloud-based platform for acute care teams that speeds up stroke triage by giving physicians fast access to DICOM imaging, patient timelines, and secure messaging across hospitals.
AI & Machine LearningDigital HealthMedical Devices
Merel Boers(Co-Founder)in
Co-investorsPerennial Partners
PCaVision combines multiparametric ultrasound imaging with AI algorithms to detect suspicious areas for prostate cancer, offering a diagnostic pathway for urologists that avoids the need for MRI.
AI & Machine LearningDigital HealthMedical Devices
Mark Bloemendaal(Founder)in
Co-investorsInvesdor
PEP Health uses AI to analyze millions of unsolicited patient comments and turn them into benchmarkable, predictive insights on care quality, patient experience, and reputation.
AI & Machine LearningDigital HealthHealthtech
Persuasive develops a platform technology for high-throughput analysis of extracellular vesicles (EVs) and is building a blood-based diagnostic test using an EV protein biomarker signature to identify chronic coronary syndrome in primary-care patients presenting with chest pain.
BiotechDigital HealthHealthtech
A company that has completed first-in-human clinical trials for its products and is pursuing regulatory approvals for worldwide commercialization.
BiotechHealthtechMedical DevicesNew Materials
POROUS develops a non-invasive ultrasound-based medical device for quantitative bone quality assessment and osteoporosis detection.
AgTechAI & Machine LearningBiotechDeep TechDigital HealthHealthtechMedical DevicesBerlin, DE
Prof. Kay Raum
Co-investorsIQ CapitalMartlet CapitalSpeedinvest
.jpeg){kind=logo}
Profionics develops host-response biomarker technology for rapid detection and diagnosis of sepsis.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesCardiff, GB
Professor Peter Ghazal(Co-founder)Darren Fergus(Co-founder & CEO)inDr Daniel White(CTO)
BoardGina Melchner von Dydiowa(Venture Partner)
Provasctec develops a cell therapy combining mesenchymal stem cells with a biodegradable delivery device to create new vascular pathways, with a lead program targeting critical limb ischemia in peripheral artery disease patients.
BiotechHealthtechMedical Devices
Holger Muller(CEO & Co-Founder)inNoel Caplice(CSO & Co-Founder)in
Respiosa develops a minimally invasive surgical implant to treat obstructive sleep apnea by preventing tongue collapse during sleep, targeting patients for whom current treatments like CPAP are ineffective or poorly tolerated.
HealthtechMedical Devices
Steven Coughlin(Founder)in
Co-investorsDeepbridge Capital
RetinaCheck was a Sino-Dutch research project and TU/e startup that developed computer-aided diagnosis software using geometric methods and deep learning to automatically analyze retinal fundus images for early detection of diabetic retinopathy and other eye diseases.
AI & Machine LearningDigital HealthMedical DevicesEindhoven, NL
Revadix develops first-in-class small molecule therapies targeting the EPAC1 signalling pathway to treat atrial fibrillation, addressing the underlying disease mechanism rather than symptoms.
BiotechDeep TechMedical DevicesToulouse, FR
Frank Lezoualc'h(Scientific Founder / Research Director at Inserm)
Rheumasense develops clinical diagnostic testing technology aimed at transforming the management and care of rheumatoid arthritis.
AI & Machine LearningDigital HealthMedical Devices
John M. Davis III(Co-Inventor, Professor of Medicine & Chair, Division of Rheumatology, Mayo Clinic)inJen Skeen(CEO)in
Sanmirna Therapeutics develops microRNA-targeted therapeutics for cancer treatment, with its lead candidate Miristen™ currently in Phase I clinical trials for acute myeloid leukemia.
AI & Machine LearningBiotechHealthtechMedical DevicesAmsterdam, US
Scinvivo develops Lumante, a catheter-based optical coherence tomography (OCT) imaging platform for real-time, minimally invasive visualization and local staging of bladder cancer during cystoscopy.
Deep TechHealthtechMedical DevicesEindhoven, NL
Marijn van Os(Co-founder & CEO)inDiederik van Lierop(Co-founder, Software/Hardware Developer)inMaaike de Jong(CMO (Chief Medical Officer))inCamile van der Heijden(CTO)inLiesbeth Geerts(CCO)inMaarten Haast(CFO)in
SERDA Therapeutics is a clinical-stage biopharmaceutical company developing a prescription wound debridement therapy that uses a proprietary proteolytic enzyme to selectively digest necrotic tissue and eschar.
BiotechMedical Devices
StarTric develops a minimally invasive transcatheter device for repairing the tricuspid heart valve, designed to replicate the open-heart Clover surgical technique for treating tricuspid regurgitation.
HardwareHealthtechMedical Devices
Michele De Bonis(Founder)Ottavio Alfieri(Founder)
Co-investorsGrowth CapitalGrowth Engine
TimeLab builds scientifically validated operational decision support software, using AI-driven systems and near-future state assessments to improve dispatch and fleet deployment for emergency services.
AI & Machine LearningDeep TechEnterprise SoftwareGovTechHealthtechAmsterdam, EU
Venous Stent develops ALTA®, a modular stent designed to treat deep venous disease in the iliac and femoral veins.
HardwareHealthtechMedical Devices
BoardCees Wittens(Venous surgeon (design expert))
Co-investorsBaird Capital
Wavefront develops quantitative 3D cell imaging technology for biomedical researchers to accelerate discoveries in cell science and healthcare applications.
AI & Machine LearningBiotechDeep TechMedical Devices
Manuel Martinez(Inventor and Co-founder)inWilson Gomes(CEO and Co-founder)in
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
ArneAxialDiaphOne TherapeuticsDiaphone TxESGExolvoGenorareImplant Preservation DevicesInnofuseLiftyaMir TherapeuticsMla DiagnosticsNeurodys TherapeuticsOcclunovaSansepsisSerdaSigilla MedicalThe Venous StentUltraTILUltratil MedicalXtrna Bio
Frequently asked questions
- How many investments has NLC made?
- NLC has 73 tracked investments.
- What stage does NLC invest at?
- NLC invests at the Pre-Seed, Seed stages.
- What sectors does NLC focus on?
- NLC focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Impact & Social Good, Longevity, Medical Devices.
- Where is NLC located?
- NLC is headquartered in Amsterdam, NL.
- Who does NLC co-invest with?
- NLC most often shares deals with BOM, Deepbridge Capital, Growth Capital, among 5 tracked co-investors.
Media · Podcasts & interviews
featuring the teamBert-Arjan Millenaar on NLC Health | Building 85+ HealthTech Startups & Crowdfunding Innovation
Odelle Technology · Bert-Arjan Millenaar
#115: Founder/CEO NLC Bert-Arjan Millenaar: How can we make more medical innovations profitable?
De Nieuwe Wereld · Bert-Arjan Millenaar
Images
Similar investors
Future Positive Capital is a venture firm backing entrepreneurs building companies that address large-scale global challenges across health, sustainability and technology.
Everywhere Ventures is an early-stage venture firm that writes pre-seed checks and is backed by a community of founder and operator LPs.
Selvedge Venture is an impact-focused investor backing founders and startups working to reduce the healthcare burden of age-related medical conditions, investing at pre-seed, seed and Series A stages.
CABHI (Centre for Aging + Brain Health Innovation) is a pan-Canadian organization that funds and supports researchers, innovators, and startups working on brain health and aging solutions, and helps healthcare and community organizations adopt them.
Relentless Venture Fund is a venture capital firm investing in companies focused on health, activity and longevity, drawing on technical, operational, venture, healthcare, high performance and social impact finance expertise.